Navigation Links
With Prostate Cancer: Waiting for Symptoms Is Not an Option
Date:7/1/2008

ith a miniscule camera that displays magnified images from inside the body. The robotic control system enables the surgeon's hand movements to be more precise, resulting in less trauma to surrounding tissue, and minimal blood loss. Men who opt for robotic laparoscopic surgery are cancer free and able to resume normal lifestyles with total control over their sexual functions and bladder. Cancer free outcomes also result from traditional open prostate surgery, but men are rendered impotent and incontinent -- both of which may never be reversed. These side effects are devastating to prostate cancer patients, and have led to failed marriages and relationships, and depression.

Instead of two to three days of hospitalization and two months of recuperation typical with open surgery, robotic surgery patients go home the next day and are back to normal activities within two weeks. These patients have an excellent chance of being cancer-free with great quality of life. For more information, call 212-241-8779 or log on to http://www.roboticoncology.com.

Media Contact: Cathy Callegari -- 212-579-1370 or cathy@callprinc.com


'/>"/>
SOURCE Dr. David Samadi, Mount Sinai Medical Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Conventional prognostic factors fail to explain better prostate cancer survival in most Asian men
2. First biomarker discovered that predicts prostate cancer outcome
3. Frequent Prostate Screens Fail to Improve Aggressive Cancer Diagnoses
4. New male sling procedure helps prostate cancer survivors who suffer from urinary incontinence
5. Us TOO Launches National SEA Blue Campaign for Prostate Cancer Awareness Month
6. Red wine compound shown to prevent prostate cancer
7. Barbershop Talks Cut Black Mens Prostate Cancer Risk
8. Generic prostate drug helps find high-risk cancers early
9. Finasteride unlikely to induce high grade prostate cancers
10. Shrinkage of prostate led to overestimation of cancer risk in trial
11. Prostate Cancer Awareness Week to Screen Thousands
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 Reportlinker.com announces that ... available in its catalogue: ,, ... Therapeutics - Market Forecasts to 2015, ... Analysis ,, http://www.reportlinker.com/p0168099/The-Future-of-Respiratory-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html ... The author has released its latest ...
(Date:12/15/2009)... NEW YORK, Dec. 15 ... research report is available in its ... of Autoimmune Diseases Therapeutics - Market ... Pipeline and Deals Analysis ... Summary ,, The author has ...
(Date:12/15/2009)... ALPHARETTA, Ga., Dec. 15 Hosted by ... the 4th annual event recognized 2009,s best eLearning ... all, were spread across 4 categories. The ... developed for the world,s largest hotelier, was selected ... Hours of Custom eLearning" category by the panel ...
(Date:12/15/2009)... Ill. and CHENNAI, India, Dec. 15 /PRNewswire-FirstCall/ ... ), the world leader in generic injectable ... (BSE: 524372, NSE: ORCHIDCHEM), a leading Indian ... beta-lactam antibiotics manufacturers globally, today announced an ... injectable finished-dosage form pharmaceuticals business for approximately ...
(Date:12/15/2009)... is being released by the American Health Information Management ... RHIT, CCS, FAHIMA ,, AHIMA President ... ,, On behalf of the A-H-I-M-A Board of Directors...it ... executive officer, Doctor Alan Dowling... ,, Back last summer ... who we knew could effectively replace Linda ...
Breaking Medicine News(10 mins):Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Respiratory Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 2Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 3Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 4Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 5Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 6Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 7Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 8Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 9Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 10Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 11Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 12Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 13Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 14Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 15Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 16Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 17Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 18Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 19Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 20Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 21Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 22Health News:Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis 23
... more than 60 orders for faster form of image-guided ... intensity-modulated radiation therapy, PALO ... ) today announced it has received more than 60 orders ... RapidArc orders have been,concentrated in North America but have also ...
... The NCCA accredited the National,Exercise & ... a five-year period, expiring March 31, 2013, ... NESTA is a professional certification organization,acting in ... education,examination, experience and ethics requirements for certification., ...
... Association urges Senators Cardin and Mikulski to quickly pass,companion ... 23 AARP thanked the,supporters and cosponsors of the ... today in the U.S. House of Representatives. The bill,prevents ... stopping,harmful cuts proposed by the administration., "Today,s vote ...
... Expert says goal is to maintain strength, not gain it, ... If you,re an athlete or fitness enthusiast who suffers a ... have to stop exercising. , , "Exercise can definitely be ... its type, the injured area should be moved and not ...
... and Tour Groups, CHICAGO, April 23 ... Bank of America Chicago Marathon has closed as ... race, marking the event,s,established capacity. A limited number ... tour groups., (Logo: http://www.newscom.com/cgi-bin/prnh/20050720/CLW086LOGO-b ), ...
... with these headaches suffer from skin discomfort, study finds, ... have migraines -- either chronic or episodic -- are ... sensitivity, new research shows. , As many as two-thirds ... condition called cutaneous allodynia. Cutaneous allodynia is skin sensitivity ...
Other Medicine News:Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 2Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 3Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 4Health News:Varian Medical Systems Announces Record Demand for New RapidArc(TM) Radiotherapy Treatment Capability 5Health News:The National Exercise & Sports Trainers Association Receives Accreditation of Its Personal Fitness Trainer Certification From the National Commission for Certifying Agencies (NCCA) 2Health News:AARP Thanks Maryland's Representatives for Supporting Bill to Protect People in Medicaid 2Health News:Exercise Plays Role in Recovery From Sports Injuries 2Health News:2008 Bank of America Chicago Marathon Registration Closes as Race Reaches 45,000 Participant Capacity 2Health News:Skin Pain, Sensitivity Rises With Migraine 2Health News:Skin Pain, Sensitivity Rises With Migraine 3
(Date:12/15/2009)... Dec. 15 Varian Medical Systems (NYSE: ... results for first quarter of fiscal year 2010 following ... 2010. The news release will be followed by ... p.m. PT. The news release and a link ... the company website at: www.varian.com/investor . To ...
(Date:12/15/2009)... Calif., Dec. 15 Masimo (Nasdaq: ... Measure-Through Motion and Low Perfusion pulse oximetry, today ... has been awarded the 2009 Frost & Sullivan ... American Patient Monitoring market. According to Frost & ... Mr. Kiani,s "unprecedented ability in understanding customer requirements, ...
(Date:12/15/2009)... Rib-X Pharmaceuticals, Inc., a company focused ... drugs for the treatment of serious multi-drug-resistant infections ... research agreement with Massachusetts General Hospital (MGH). ... collaboration, Dr. David Hooper of MGH will evaluate ... model to determine resistance development and to validate ...
Breaking Medicine Technology:Varian Medical Systems Schedules First Quarter FY2010 News Release and Conference Call 2Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 2Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 3Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 4Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 5Masimo Chairman and CEO Joe Kiani Receives 2009 Frost & Sullivan CEO of the Year Award 6Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 2Rib-X Pharmaceuticals Enters into Collaborative Agreement on Delafloxacin with Massachusetts General Hospital 3American Community Introduces Latitude 28TM 29 Health Plan for Employer Groups in Nebraska 55321 1American Community Introduces Latitude 28TM 29 Health Plan for Employer Groups in Nebraska 55321 2NexBio 28R 29 Demonstrates DAS181 28Fludase 28R 29 29 a Broad Spectrum Drug Candidate Inhibits Influenza Viral Infection in Human Lung Tissue 13689 1NexBio 28R 29 Demonstrates DAS181 28Fludase 28R 29 29 a Broad Spectrum Drug Candidate Inhibits Influenza Viral Infection in Human Lung Tissue 13689 2NexBio 28R 29 Demonstrates DAS181 28Fludase 28R 29 29 a Broad Spectrum Drug Candidate Inhibits Influenza Viral Infection in Human Lung Tissue 13689 3NexBio 28R 29 Demonstrates DAS181 28Fludase 28R 29 29 a Broad Spectrum Drug Candidate Inhibits Influenza Viral Infection in Human Lung Tissue 13689 4SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 1SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 2SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 3SuperSonic Imagine Receives FDA Approval for Aixplorer Ultrasound System 13688 4
... INDIANAPOLIS, Nov. 6 Eli Lilly and Company,(NYSE: ... from the National,Committee for Quality Assurance (NCQA) for ... Tools that Empower(TM) Depression Care Management Program is ... driving the standard of,patient care around Major Depressive ...
... FALLS, N.J., Nov. 5 CANTEL MEDICAL,CORP. (NYSE: ... significant,interest from schools for its hand sanitization and ... of MRSA,(Methicillin-resistant Staphylococcus aureus) skin infections. According ... CEO, "We are,in contact with numerous school officials ...
Other Medicine Technology:Lilly Receives NCQA Design Certification for Depression Care Management Program 2Lilly Receives NCQA Design Certification for Depression Care Management Program 3Cantel Medical Corp.'s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products 2Cantel Medical Corp.'s Crosstex Subsidiary Addresses School MRSA Concerns With SaniTyze(TM) Brand Hand Sanitizer and Sanitex(R) Surface Disinfecting Line of Products 3
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: